Goldman Sachs Group Inc Allakos Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Allakos Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 15,235 shares of ALLK stock, worth $4,418. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,235
Previous 14,141 7.74%
Holding current value
$4,418
Previous $9,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$0.62 - $1.5 $678 - $1,641
1,094 Added 7.74%
15,235 $18,000
Q3 2024

Nov 14, 2024
SELL
$0.54 - $0.92 $177,944 - $303,164
-329,527 Reduced 95.89%
14,141 $9,000
Q2 2024

Aug 13, 2024
BUY
$1.0 - $1.45 $116,268 - $168,588
116,268 Added 51.13%
343,668 $343,000
Q1 2024

May 15, 2024
SELL
$1.02 - $3.23 $48,482 - $153,528
-47,532 Reduced 17.29%
227,400 $286,000
Q4 2023

Feb 13, 2024
BUY
$1.72 - $3.18 $7,127 - $13,177
4,144 Added 1.53%
274,932 $750,000
Q3 2023

May 14, 2024
SELL
$2.13 - $5.55 $8,826 - $22,999
-4,144 Reduced 1.51%
270,788 $614,000
Q3 2023

Nov 14, 2023
SELL
$2.13 - $5.55 $342,770 - $893,133
-160,925 Reduced 37.28%
270,788 $614,000
Q2 2023

May 14, 2024
SELL
$3.6 - $5.25 $332,150 - $484,386
-92,264 Reduced 17.61%
431,713 $1.88 Million
Q2 2023

Aug 14, 2023
SELL
$3.6 - $5.25 $332,150 - $484,386
-92,264 Reduced 17.61%
431,713 $1.88 Million
Q1 2023

May 14, 2024
BUY
$4.3 - $8.27 $183,764 - $353,426
42,736 Added 8.88%
523,977 $2.33 Million
Q1 2023

May 11, 2023
BUY
$4.3 - $8.27 $183,764 - $353,426
42,736 Added 8.88%
523,977 $2.33 Million
Q4 2022

May 14, 2024
BUY
$5.66 - $8.42 $2.07 Million - $3.07 Million
365,030 Added 314.11%
481,241 $4.05 Million
Q4 2022

Feb 13, 2023
BUY
$5.66 - $8.42 $2.07 Million - $3.07 Million
365,030 Added 314.11%
481,241 $4.05 Million
Q3 2022

May 14, 2024
SELL
$3.02 - $6.12 $1.31 Million - $2.66 Million
-435,305 Reduced 78.93%
116,211 $711,000
Q3 2022

Nov 10, 2022
SELL
$3.02 - $6.12 $1.31 Million - $2.66 Million
-435,305 Reduced 78.93%
116,211 $0
Q2 2022

May 14, 2024
BUY
$2.6 - $6.14 $719,118 - $1.7 Million
276,584 Added 100.6%
551,516 $1.73 Million
Q2 2022

Aug 15, 2022
SELL
$2.6 - $6.14 $1.18 Million - $2.8 Million
-455,580 Reduced 45.24%
551,516 $1.73 Million
Q1 2022

May 16, 2022
BUY
$5.08 - $9.81 $3.69 Million - $7.12 Million
725,818 Added 258.04%
1,007,096 $5.74 Million
Q4 2021

Feb 14, 2022
BUY
$8.55 - $111.89 $378,200 - $4.95 Million
44,234 Added 18.66%
281,278 $2.75 Million
Q3 2021

Nov 10, 2021
BUY
$76.53 - $110.43 $18.1 Million - $26.2 Million
237,044 New
237,044 $25.1 Million

Others Institutions Holding ALLK

# of Institutions
79
Shares Held
68.8M
Call Options Held
20.9K
Put Options Held
0
View Full List

About Allakos Inc.

ALLK Quotes by TradingView
  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $24.6M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email